Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial
Christopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Lancet (London, England)
|
March 24, 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P Dematteo, Karla V Ballman, Cristina R Antonescu, et al.
Cancers
|
July 26, 2020
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
Carol M Amato, Jennifer D Hintzsche, Keith Wells, et al.
Frontiers in Oncology
|
November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Decitabine reverses innate immune gene suppression in rare melanomas
Morgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 4, 2021
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors
Jessica S W Borgers, Richard P Tobin, Robert J Torphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2022
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
Richard P Tobin, Dasha T Cogswell, Victoria M Cates, et al.
Clinical & Translational Immunology
|
January 14, 2022
Circulating CD8<sup>+</sup> mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients
Victoria M Vorwald, Dana M Davis, Robert J Van Gulick, et al.
Cells
|
December 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy
Islam Eljilany, Sam Coleman, Aik Choon Tan, et al.
Science Immunology
|
June 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
William H Palmer, Laura Ann Leaton, Ana Campos Codo, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial
Christopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Lancet (London, England)
|
March 24, 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P Dematteo, Karla V Ballman, Cristina R Antonescu, et al.
Cancers
|
July 26, 2020
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
Carol M Amato, Jennifer D Hintzsche, Keith Wells, et al.
Frontiers in Oncology
|
November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Decitabine reverses innate immune gene suppression in rare melanomas
Morgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 4, 2021
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors
Jessica S W Borgers, Richard P Tobin, Robert J Torphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2022
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
Richard P Tobin, Dasha T Cogswell, Victoria M Cates, et al.
Clinical & Translational Immunology
|
January 14, 2022
Circulating CD8<sup>+</sup> mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients
Victoria M Vorwald, Dana M Davis, Robert J Van Gulick, et al.
Cells
|
December 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy
Islam Eljilany, Sam Coleman, Aik Choon Tan, et al.
Science Immunology
|
June 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
William H Palmer, Laura Ann Leaton, Ana Campos Codo, et al.
Page
of 18